Deep Science Ventures vs KaliVir Immunotherapeutics, Inc.
Deep Science Ventures vs KaliVir Immunotherapeutics, Inc., compared side by side on 18 data points: what each one does, how big it is, what it has raised, the tech running each site, and what users report. We score both out of 100 on traction, team and visibility: Deep Science Ventures is on 44/100 and KaliVir Immunotherapeutics, Inc. on 28/100.
Where each one leads
Deep Science Ventures
- our overall score: 44/100 against 28/100
- domain rating: 52/100 against 10/100
- funding raised: $63.0M against $14.0M
KaliVir Immunotherapeutics, Inc.
- agent readiness: 40/100 against 21/100
At a glance
| Measure | Deep Science Ventures | KaliVir Immunotherapeutics, Inc. |
|---|---|---|
| What it is | Empowering Venture Scientists to solve neglected health and planetary challenges through an entrepreneurship-focused doctoral training program. | Clinical-stage biotechnology company developing multi-mechanistic oncolytic immunotherapy programs for cancer treatment. |
| Category | Biotechnology, Health, Sustainability, Deep Tech | Biotechnology, Health, Pharmaceuticals, Oncology |
| Sells toBusiness model | B2B2C | B2B |
| Offering | Platform | Platform |
| Founded | 2019 | 2019 |
| Headquarters | London, United Kingdom | Pittsburgh, United States |
| Status | Active | Active |
Size, funding and growth
| Measure | Deep Science Ventures | KaliVir Immunotherapeutics, Inc. |
|---|---|---|
| Employees | Not published | 29 |
| Total funding | $63.0M | $14.0M |
| Latest round | Series C | Series A Extension |
| Valuation | $1.1B | $1.1B |
| LinkedIn followers | Not published | 1,604 |
StartupHub scores
Our own 0-100 ratings. They measure company strength and site quality, not which product suits you.
| Measure | Deep Science Ventures | KaliVir Immunotherapeutics, Inc. |
|---|---|---|
| StartupHub scoreOur 0-100 rating | 44/100 | 28/100 |
| Traction | 39/100 | 39/100 |
| Team | 30/100 | 50/100 |
| Search visibility | 18/100 | Not published |
| Quality | 55/100 | Not published |
| Agent readinessHow well an AI agent can read and act on the site | F (21/100) | D (40/100) |
| Domain ratingLink authority, 0-100 | 52/100 | 10/100 |
Technology
Detected on each public site, so it reflects the marketing stack as well as the product.
| Measure | Deep Science Ventures | KaliVir Immunotherapeutics, Inc. |
|---|---|---|
| CDN | Cloudflare | Cloudflare |
| CMS | Webflow | WordPress |
| Frameworks | Tailwind CSS, Bootstrap | Jquery |
| Analytics | Google Analytics 4 | Not detected |
| Support stack | HubSpot | Not detected |
What users say
| Measure | Deep Science Ventures | KaliVir Immunotherapeutics, Inc. |
|---|---|---|
| Reddit sentimentThreads we track | Not published | 0 positive, 0 negative across 1 thread |
“SIGA | SIGA Announces Oncology Collaboration with KaliVir Immunotherapeutics.”r/StockTitan
Deep Science Ventures vs KaliVir Immunotherapeutics, Inc.: common questions
Which is better, Deep Science Ventures or KaliVir Immunotherapeutics, Inc.?
On our 0-100 score Deep Science Ventures rates higher (44/100 against 28/100). The score weights traction, team, visibility and profile completeness, so it reflects company strength rather than which product suits you. We compare the two on 18 data points above: read the rows that match what you are buying for.
How do Deep Science Ventures and KaliVir Immunotherapeutics, Inc. compare on the numbers?
Deep Science Ventures leads on our overall score (44/100 against 28/100), domain rating (52/100 against 10/100), funding raised ($63.0M against $14.0M). KaliVir Immunotherapeutics, Inc. leads on agent readiness (40/100 against 21/100).
What do real users say about Deep Science Ventures and KaliVir Immunotherapeutics, Inc.?
KaliVir Immunotherapeutics, Inc.: 0 positive and 0 negative mentions across 1 Reddit threads we track, mostly in r/StockTitan.
Read the full Deep Science Ventures review and pricing or the KaliVir Immunotherapeutics, Inc. review and pricing. You can also browse other Deep Science Ventures alternatives we track.

